{"id":36113,"date":"2026-07-14T08:43:27","date_gmt":"2026-07-14T13:43:27","guid":{"rendered":"https:\/\/myeloma.ca\/?page_id=36113"},"modified":"2026-07-14T08:44:28","modified_gmt":"2026-07-14T13:44:28","slug":"myelome-canada-dans-la-litterature-scientifique","status":"publish","type":"page","link":"https:\/\/myeloma.ca\/fr\/science-et-recherche\/myelome-canada-dans-la-litterature-scientifique\/","title":{"rendered":"My\u00e9lome Canada dans la litt\u00e9rature scientifique"},"content":{"rendered":"<div class=\"page-intro-block   block_38bd8ba2b9840127581580fa07e7aafd\">\n    <div class=\"container\">\n        <div class=\"left-content\">\n            <div class=\"content\">\n                <h1>My\u00e9lome Canada dans la <strong class='second-font-family is-italic is-italic-fw'>litt\u00e9rature scientifique<\/strong><\/h1>\n            <\/div>\n            <div class=\"bottom-content\">\n                <div class=\"actions-btns-wrapper\">\n                    <a class=\"print-btn\" href=\"#\">\n                        <svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"13.545\" height=\"14.195\" viewBox=\"0 0 13.545 14.195\"><path d=\"M13.786,9.785v-2.6H7.759v2.6H6.743V6H14.8V9.785Zm-8.77,1.183h0Zm10.142,1.873a.457.457,0,0,0,.356-.177.639.639,0,0,0,0-.828.445.445,0,0,0-.711,0,.639.639,0,0,0,0,.828A.457.457,0,0,0,15.158,12.841Zm-1.371,6.171V15.227H7.759v3.785ZM14.8,20.2H6.743v-3.47H4v-4.85a2.2,2.2,0,0,1,.516-1.489,1.619,1.619,0,0,1,1.278-.6H15.75a1.619,1.619,0,0,1,1.278.6,2.2,2.2,0,0,1,.516,1.489v4.85H14.8Zm1.727-4.653V11.875a.963.963,0,0,0-.22-.651.7.7,0,0,0-.559-.256H5.795a.7.7,0,0,0-.559.256.963.963,0,0,0-.22.651v3.667H6.743v-1.5H14.8v1.5Z\" transform=\"translate(-4 -6)\" fill=\"#3e3a3b\"\/><\/svg>\n                        <span>Imprimer<\/span>\n                    <\/a>\n                    <a class=\"share-btn\" href=\"mailto:?subject=I wanted you to see this!&amp;body=https:\/\/myeloma.ca\/fr\/science-et-recherche\/myelome-canada-dans-la-litterature-scientifique\/\">\n                        <svg height=\"14.195\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 512 512\"><path d=\"M64 96c-17.7 0-32 14.3-32 32v39.9L227.6 311.3c16.9 12.4 39.9 12.4 56.8 0L480 167.9V128c0-17.7-14.3-32-32-32H64zM32 207.6V384c0 17.7 14.3 32 32 32H448c17.7 0 32-14.3 32-32V207.6L303.3 337.1c-28.2 20.6-66.5 20.6-94.6 0L32 207.6zM0 128C0 92.7 28.7 64 64 64H448c35.3 0 64 28.7 64 64V384c0 35.3-28.7 64-64 64H64c-35.3 0-64-28.7-64-64V128z\"\/><\/svg>\n                        <span>Partager<\/span>\n                    <\/a>\n                <\/div>\n                <div class=\"lb-breadcrumb\">\n                    <div class=\"lb-breadcrumbs\"><span><a href=\"https:\/\/myeloma.ca\/fr\/\">Accueil<\/a><\/span><span class=\"lb-breadcrumb-separator\"> | <\/span><\/div>                <\/div>\n            <\/div>\n\n        <\/div>\n    <\/div>\n    <div class=\"page-intro-image-wrapper\">\n\t\t<img loading=\"lazy\" decoding=\"async\" width=\"1608\" height=\"1206\" src=\"https:\/\/myeloma.ca\/wp-content\/uploads\/Gabe-PROM-article-2026.jpg\" class=\"attachment-full size-full\" alt=\"\" srcset=\"https:\/\/myeloma.ca\/wp-content\/uploads\/Gabe-PROM-article-2026.jpg 1608w, https:\/\/myeloma.ca\/wp-content\/uploads\/Gabe-PROM-article-2026-300x225.jpg 300w, https:\/\/myeloma.ca\/wp-content\/uploads\/Gabe-PROM-article-2026-1024x768.jpg 1024w, https:\/\/myeloma.ca\/wp-content\/uploads\/Gabe-PROM-article-2026-768x576.jpg 768w, https:\/\/myeloma.ca\/wp-content\/uploads\/Gabe-PROM-article-2026-1536x1152.jpg 1536w\" sizes=\"auto, (max-width: 1608px) 100vw, 1608px\" \/>    <\/div>\n        <div class=\"left-content mobile\">\n            <div class=\"bottom-content\">\n                <div class=\"actions-btns-wrapper\">\n                    <a class=\"print-btn\" href=\"#\">\n                        <svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"13.545\" height=\"14.195\" viewBox=\"0 0 13.545 14.195\"><path d=\"M13.786,9.785v-2.6H7.759v2.6H6.743V6H14.8V9.785Zm-8.77,1.183h0Zm10.142,1.873a.457.457,0,0,0,.356-.177.639.639,0,0,0,0-.828.445.445,0,0,0-.711,0,.639.639,0,0,0,0,.828A.457.457,0,0,0,15.158,12.841Zm-1.371,6.171V15.227H7.759v3.785ZM14.8,20.2H6.743v-3.47H4v-4.85a2.2,2.2,0,0,1,.516-1.489,1.619,1.619,0,0,1,1.278-.6H15.75a1.619,1.619,0,0,1,1.278.6,2.2,2.2,0,0,1,.516,1.489v4.85H14.8Zm1.727-4.653V11.875a.963.963,0,0,0-.22-.651.7.7,0,0,0-.559-.256H5.795a.7.7,0,0,0-.559.256.963.963,0,0,0-.22.651v3.667H6.743v-1.5H14.8v1.5Z\" transform=\"translate(-4 -6)\" fill=\"#3e3a3b\"\/><\/svg>\n                        <span>Imprimer<\/span>\n                    <\/a>\n                    <a class=\"share-btn\" href=\"mailto:?subject=I wanted you to see this!&amp;body=https:\/\/myeloma.ca\/fr\/science-et-recherche\/myelome-canada-dans-la-litterature-scientifique\/\">\n                        <svg height=\"14.195\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" viewBox=\"0 0 512 512\"><path d=\"M64 96c-17.7 0-32 14.3-32 32v39.9L227.6 311.3c16.9 12.4 39.9 12.4 56.8 0L480 167.9V128c0-17.7-14.3-32-32-32H64zM32 207.6V384c0 17.7 14.3 32 32 32H448c17.7 0 32-14.3 32-32V207.6L303.3 337.1c-28.2 20.6-66.5 20.6-94.6 0L32 207.6zM0 128C0 92.7 28.7 64 64 64H448c35.3 0 64 28.7 64 64V384c0 35.3-28.7 64-64 64H64c-35.3 0-64-28.7-64-64V128z\"\/><\/svg>\n                        <span>Partager<\/span>\n                    <\/a>\n                <\/div>\n            <\/div>\n        <\/div>\n    <\/div>\n\n\n<!-- EDIT ONLY THIS SECTION -->\n<script>\nconst dotSections = [\n  {\n    id: 'qualite-de-vie',\n    label: 'Qualit\u00e9 de vie'\n  },\n  {\n    id: 'politiques-de-sante',\n    label: 'Politiques de sant\u00e9'\n  },\n  {\n    id: 'lignes-directrices-consensuelles',\n    label: '<glwrap>Lignes directrices consensuelles<\/glwrap>'\n  }\n];\n<\/script>\n\n<!-- DOT NAVIGATION -->\n<nav id=\"dot-nav\" aria-label=\"Page sections\" style=\"\n    position: fixed;\n    top: 50%;\n    transform: translateY(-50%);\n    z-index: 100;\n    display: flex;\n    flex-direction: column;\n    gap: 14px;\n    align-items: flex-start;\n  \"><\/nav>\n<!-- STYLES -->\n<style>\n#dot-nav {\n  left: 24px;\n}\n@media (max-width: 768px) {\n  #dot-nav {\n    left: 12px;\n  }\n}\n#dot-nav .dot-link {\n  display: flex;\n  align-items: center;\n  gap: 8px;\n  text-decoration: none;\n}\n#dot-nav .dot {\n  width: 7px;\n  height: 7px;\n  border-radius: 50%;\n  background: #ccc;\n  transition: background-color 0.2s;\n  flex-shrink: 0;\n}\n#dot-nav .dot.active {\n  background: #a6192e !important;\n}\n#dot-nav .dot-label {\n  font-size: 12px;\n  color: #3e3a3b;\n  opacity: 0;\n  transition: opacity 0.2s;\n}\n#dot-nav .dot-link:hover .dot-label {\n  opacity: 1;\n}\n<\/style>\n<!-- SCRIPT -->\n<script>\n(function () {\n  const nav = document.getElementById('dot-nav');\n  dotSections.forEach(section => {\n    nav.insertAdjacentHTML(\n      'beforeend',\n      `\n      <a href=\"#${section.id}\" class=\"dot-link\">\n        <span class=\"dot\"><\/span>\n        <span class=\"dot-label\">${section.label}<\/span>\n      <\/a>\n      `\n    );\n  });\n  let lastIdx = -1;\n  function tick() {\n    let activeIdx = -1;\n    const triggerLine = window.innerHeight * 0.5;\n    dotSections.forEach((section, i) => {\n      const target = document.getElementById(section.id);\n      if (!target) return;\n      const top = target.getBoundingClientRect().top;\n      if (top <= triggerLine) {\n        activeIdx = i;\n      }\n    });\n    const lastSection =\n      document.getElementById(\n        dotSections[dotSections.length - 1].id\n      );\n    if (lastSection) {\n      const rect =\n        lastSection.getBoundingClientRect();\n      if (rect.top < -window.innerHeight * 0.5) {\n        activeIdx = -1;\n      }\n    }\n    if (activeIdx !== lastIdx) {\n      lastIdx = activeIdx;\n      document\n        .querySelectorAll('#dot-nav .dot')\n        .forEach((dot, i) => {\n          dot.classList.toggle(\n            'active',\n            i === activeIdx\n          );\n        });\n    }\n    requestAnimationFrame(tick);\n  }\n  requestAnimationFrame(tick);\n})();\n<\/script>\n\n\n\n<div class=\"wp-block-group container is-layout-constrained wp-block-group-is-layout-constrained\" style=\"padding-top:3rem;padding-bottom:0rem\">\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-8f761849 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-vertically-aligned-center is-layout-flow wp-block-column-is-layout-flow\" style=\"padding-top:0;padding-right:0rem;padding-bottom:0;padding-left:0rem;flex-basis:33.33%\">\n<!-- EDIT ONLY THIS SECTION -->\n\n<script>\nconst sections = [\n  {\n    id: 'qualite-de-vie',\n    label: 'Exp\u00e9rience des patients et qualit\u00e9 de vie'\n  },\n  {\n    id: 'politiques-de-sante',\n    label: 'Politiques de sant\u00e9, acc\u00e8s aux traitements et donn\u00e9es probantes en contexte de vie r\u00e9elle'\n  },\n  {\n    id: 'lignes-directrices-consensuelles',\n    label: '<glwrap>Lignes directrices consensuelles et recommandations de pratique clinique<\/glwrap>'\n  }\n];\n<\/script>\n\n<!-- STYLES -->\n\n<style>\n.toc-link {\n  transition: color 0.2s;\n}\n\n.toc-link:hover {\n  color: #a6192e;\n}\n<\/style>\n\n<!-- MENU -->\n\n<p style=\"\n    font-size:12px;\n    letter-spacing:0.08em;\n    text-transform:uppercase;\n    color:#888;\n    margin:0 0 1.25rem;\n    font-weight:500;\n    font-family:'Proxima Nova',sans-serif;\n  \">\n  On this page\n<\/p>\n\n<div id=\"toc-container\"><\/div>\n\n<!-- SCRIPT -->\n\n<script>\n(function () {\n\n  const container =\n    document.getElementById('toc-container');\n\n  sections.forEach((section, index) => {\n\n    const border =\n      index < sections.length - 1\n        ? 'border-bottom:1px solid #eee;'\n        : '';\n\n    container.insertAdjacentHTML(\n      'beforeend',\n      `\n      <a\n        href=\"#${section.id}\"\n        class=\"toc-link\"\n        style=\"\n          display:block;\n          padding:0.75rem 0;\n          text-decoration:none;\n          color:inherit;\n          font-size:14px;\n          font-family:'Proxima Nova',sans-serif;\n        \"\n      >\n        ${section.label}\n      <\/a>\n      `\n    );\n\n  });\n\n})();\n<\/script>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-vertically-aligned-center has-custom-css is-layout-flow wp-block-column-is-layout-flow wp-custom-css-853b67fd\" style=\"flex-basis:66.66%\">\n<h2 class=\"wp-block-heading\">Les contributions de notre \u00e9quipe \u00e0 la recherche sur le my\u00e9lome<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><glwrap>Le personnel de My\u00e9lome Canada contribue activement et de fa\u00e7on continue \u00e0 la recherche et \u00e0 l&rsquo;\u00e9laboration de politiques qui fa\u00e7onnent les soins li\u00e9s au my\u00e9lome multiple. Vous trouverez ci-dessous une s\u00e9lection de publications \u00e9valu\u00e9es par les pairs, de lignes directrices consensuelles et de travaux de recherche ax\u00e9s sur les patients auxquels les membres de notre \u00e9quipe ont contribu\u00e9 \u00e0 titre d&rsquo;auteurs ou de coauteurs.<\/glwrap><\/p>\n\n\n<\/div>\n<\/div>\n<\/div>\n\n\n\n<div id=\"qualite-de-vie\" class=\"wp-block-group is-layout-constrained wp-block-group-is-layout-constrained\"><div class=\" content-1-block wp-elements-5a3b9db2d512a0db132c4e9d42de6893 m-pt1  block_0e4ed0da65341560135ff65dc4404f76  \" style=\"padding-top: 3rem;padding-bottom: var(--wp--preset--spacing--60);background-color: var(--lb--light-grey);color: #3E3A3B;\">\n    <div class=\"container\">\n\t\t        <div class=\"content\">\n\t\t\t<h2 style=\"text-align: center;\">Exp\u00e9rience des patients et qualit\u00e9 de vie<\/h2>\n        <\/div>\n    <\/div>\n<\/div>\n\n<div class=\" horizontal-card-block wp-elements-e7d48d8a8a96f8996fe2c0da759f2bed   block_f83bca84389074145b44c2e22fb0c165\" style=\"padding-top: var(--wp--preset--spacing--30);padding-bottom: var(--wp--preset--spacing--60);text-align: left;background-color: var(--lb--light-grey);color: #3E3A3B;\">\n    <div class=\"container\">\n        <div>\n                            <div class=\"horizontal-card-icon\"><img loading=\"lazy\" decoding=\"async\" width=\"850\" height=\"1100\" src=\"https:\/\/myeloma.ca\/wp-content\/uploads\/Paper-bridging-perspectives.png\" class=\"attachment-full size-full\" alt=\"\" srcset=\"https:\/\/myeloma.ca\/wp-content\/uploads\/Paper-bridging-perspectives.png 850w, https:\/\/myeloma.ca\/wp-content\/uploads\/Paper-bridging-perspectives-232x300.png 232w, https:\/\/myeloma.ca\/wp-content\/uploads\/Paper-bridging-perspectives-791x1024.png 791w, https:\/\/myeloma.ca\/wp-content\/uploads\/Paper-bridging-perspectives-768x994.png 768w\" sizes=\"auto, (max-width: 850px) 100vw, 850px\" \/><\/div>\n                        <div class=\"content\">\n                <glwrap><\/p>\n<h3>Consultez l\u2019article intitul\u00e9 \u00ab Bridging Perspectives: How Canadian Patients and Caregivers View Quality of Life in Multiple Myeloma Compared to Validated Instruments \u00bb (en anglais)<\/h3>\n<p style=\"margin: 6px 0 2px;\">J. Patenaude, A. L\u00e9gar\u00e9, F. Dupont, <strong>Gabriele Colasurdo<\/strong>, <strong>Martine Elias<\/strong>, C. Beauchemin, J. Lachaine<\/p>\n<p style=\"font-size: 0.85em; color: #888888; margin: 0 0 10px;\">publi\u00e9 en mars 2026 dans la revue <em>Current Oncology<\/em><\/p>\n<hr style=\"margin: 10px 0 14px;\">\n<p>Sondage men\u00e9 aupr\u00e8s de plus de 300 patients canadiens et de 100 proches aidants afin de comparer leur \u00e9valuation de leur qualit\u00e9 de vie avec ce que mesurent les questionnaires cliniques standards..<\/p>\n<p><div class=\"lb-button-wrapper\"><a class=\"btn-with-icon \" target=\"_blank\" href=\"https:\/\/www.mdpi.com\/1718-7729\/33\/3\/174\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" width=\"20\" height=\"20\" viewBox=\"0 0 20 20\"> <g transform=\"translate(-406 -2843)\"> <circle cx=\"10\" cy=\"10\" r=\"10\" transform=\"translate(406 2843)\" fill=\"#1c596c\"\/> <g transform=\"translate(412.135 2845)\"> <g transform=\"translate(10.732 7.866) rotate(135)\"> <path d=\"M0,4.968V0H4.968\" transform=\"translate(3.389 2.774)\" fill=\"none\" stroke=\"#fff\" stroke-linecap=\"round\" stroke-miterlimit=\"10\" stroke-width=\"1\"\/> <\/g> <\/g> <\/g> <\/svg><span>Lire l&rsquo;\u00e9tude<\/span><\/a><\/div><br \/>\n<\/glwrap>\n            <\/div>\n        <\/div>\n    <\/div>\n<\/div>\n\n<div class=\" horizontal-card-block wp-elements-56a0062cc65a83fad5ac88993c3f299c   block_1c08f618465b8a4dcddf8323862b7288\" style=\"padding-top: var(--wp--preset--spacing--30);padding-bottom: 3rem;text-align: left;background-color: var(--lb--light-grey);color: #3E3A3B;\">\n    <div class=\"container\">\n        <div>\n                            <div class=\"horizontal-card-icon\"><img loading=\"lazy\" decoding=\"async\" width=\"850\" height=\"1100\" src=\"https:\/\/myeloma.ca\/wp-content\/uploads\/Paper-discrete-choice-experiment.png\" class=\"attachment-full size-full\" alt=\"\" srcset=\"https:\/\/myeloma.ca\/wp-content\/uploads\/Paper-discrete-choice-experiment.png 850w, https:\/\/myeloma.ca\/wp-content\/uploads\/Paper-discrete-choice-experiment-232x300.png 232w, https:\/\/myeloma.ca\/wp-content\/uploads\/Paper-discrete-choice-experiment-791x1024.png 791w, https:\/\/myeloma.ca\/wp-content\/uploads\/Paper-discrete-choice-experiment-768x994.png 768w\" sizes=\"auto, (max-width: 850px) 100vw, 850px\" \/><\/div>\n                        <div class=\"content\">\n                <glwrap><\/p>\n<h3>Consultez l\u2019article intitul\u00e9 \u00ab Exploring What Matters Most to Patients in Relapsed Refractory Multiple Myeloma Treatment: A Canadian Discrete Choice Experiment with Patients, Caregivers and Physicians \u00bb (en anglais)<\/h3>\n<p style=\"margin: 6px 0 2px;\">Rebekah Hall, Gin Nie Chua, Bonnie Macfarlane, Richard K. Plante, Kun Shi, Stephanie Soltys, Arleigh McCurdy, <strong>Martine Elias<\/strong>, <strong>Jessy Ranger<\/strong><\/p>\n<p style=\"font-size: 0.85em; color: #888888; margin: 0 0 10px;\">publi\u00e9 en juillet 2025 dans la revue <em>BMC Cancer<\/em><\/p>\n<hr style=\"margin: 10px 0 14px;\">\n<p>Sondage men\u00e9 aupr\u00e8s de 101 patients canadiens atteints d&rsquo;un my\u00e9lome multiple r\u00e9cidivant ou r\u00e9fractaire, ainsi que de 46 proches aidants et 49 m\u00e9decins, afin de mieux comprendre comment l&rsquo;impact de la maladie sur la qualit\u00e9 de vie influence les priorit\u00e9s de traitement.<\/p>\n<p><div class=\"lb-button-wrapper\"><a class=\"btn-with-icon \" target=\"_blank\" href=\"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14490-5\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" width=\"20\" height=\"20\" viewBox=\"0 0 20 20\"> <g transform=\"translate(-406 -2843)\"> <circle cx=\"10\" cy=\"10\" r=\"10\" transform=\"translate(406 2843)\" fill=\"#1c596c\"\/> <g transform=\"translate(412.135 2845)\"> <g transform=\"translate(10.732 7.866) rotate(135)\"> <path d=\"M0,4.968V0H4.968\" transform=\"translate(3.389 2.774)\" fill=\"none\" stroke=\"#fff\" stroke-linecap=\"round\" stroke-miterlimit=\"10\" stroke-width=\"1\"\/> <\/g> <\/g> <\/g> <\/svg><span>Lire l&rsquo;\u00e9tude<\/span><\/a><\/div><br \/>\n<\/glwrap>\n            <\/div>\n        <\/div>\n    <\/div>\n<\/div><\/div>\n\n\n\n<div id=\"politiques-de-sante\" class=\"wp-block-group is-layout-constrained wp-block-group-is-layout-constrained\"><div class=\" content-1-block m-pt1  block_d79bcd87c7d0a9663d3fbe8a16f8254c  \" style=\"padding-top: 3rem;padding-bottom: var(--wp--preset--spacing--60);\">\n    <div class=\"container\">\n\t\t        <div class=\"content\">\n\t\t\t<h2 style=\"text-align: center;\">Politiques de sant\u00e9, acc\u00e8s aux traitements et donn\u00e9es probantes en contexte de vie r\u00e9elle<\/h2>\n        <\/div>\n    <\/div>\n<\/div>\n\n<div class=\" horizontal-card-block img-gray-border   block_d73ea68a62f531989d50b8071872ea17\" style=\"padding-bottom: var(--wp--preset--spacing--60);\">\n    <div class=\"container\">\n        <div>\n                            <div class=\"horizontal-card-icon\"><img loading=\"lazy\" decoding=\"async\" width=\"850\" height=\"1100\" src=\"https:\/\/myeloma.ca\/wp-content\/uploads\/Paper-systemic-delays.png\" class=\"attachment-full size-full\" alt=\"\" srcset=\"https:\/\/myeloma.ca\/wp-content\/uploads\/Paper-systemic-delays.png 850w, https:\/\/myeloma.ca\/wp-content\/uploads\/Paper-systemic-delays-232x300.png 232w, https:\/\/myeloma.ca\/wp-content\/uploads\/Paper-systemic-delays-791x1024.png 791w, https:\/\/myeloma.ca\/wp-content\/uploads\/Paper-systemic-delays-768x994.png 768w\" sizes=\"auto, (max-width: 850px) 100vw, 850px\" \/><\/div>\n                        <div class=\"content\">\n                <glwrap><\/p>\n<h3>Consultez l\u2019article intitul\u00e9 \u00ab Impact of Systemic Delays for Patient Access to Oncology Drugs on Clinical, Economic, and Quality of Life Outcomes in Canada \u00bb (en anglais)<\/h3>\n<p style=\"margin: 6px 0 2px;\">Sandeep Sehdev, Joanna Gotfrit, <strong>Martine Elias<\/strong>, Barry D. Stein<\/p>\n<p style=\"font-size: 0.85em; color: #888888; margin: 0 0 10px;\">publi\u00e9 en mars 2024 dans la revue <em>Current Oncology<\/em><\/p>\n<hr style=\"margin: 10px 0 14px;\">\n<p>Passe en revue les r\u00e9sultats d\u2019\u00e9tudes montrant que les d\u00e9lais li\u00e9s aux processus d&rsquo;approbation et de remboursement des m\u00e9dicaments au Canada peuvent priver les patients de plusieurs mois, voire de plusieurs ann\u00e9es de survie, entra\u00eener un lourd fardeau financier et nuire \u00e0 leur qualit\u00e9 de vie.<\/p>\n<p><div class=\"lb-button-wrapper\"><a class=\"btn-with-icon \" target=\"_blank\" href=\"https:\/\/doi.org\/10.3390\/curroncol31030110\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" width=\"20\" height=\"20\" viewBox=\"0 0 20 20\"> <g transform=\"translate(-406 -2843)\"> <circle cx=\"10\" cy=\"10\" r=\"10\" transform=\"translate(406 2843)\" fill=\"#1c596c\"\/> <g transform=\"translate(412.135 2845)\"> <g transform=\"translate(10.732 7.866) rotate(135)\"> <path d=\"M0,4.968V0H4.968\" transform=\"translate(3.389 2.774)\" fill=\"none\" stroke=\"#fff\" stroke-linecap=\"round\" stroke-miterlimit=\"10\" stroke-width=\"1\"\/> <\/g> <\/g> <\/g> <\/svg><span>Lire l&rsquo;\u00e9tude<\/span><\/a><\/div><br \/>\n<\/glwrap>\n            <\/div>\n        <\/div>\n    <\/div>\n<\/div>\n\n<div class=\" horizontal-card-block img-gray-border   block_8198b73c86e1575876ba6a0e4abe49d2\" style=\"padding-bottom: 3rem;\">\n    <div class=\"container\">\n        <div>\n                            <div class=\"horizontal-card-icon\"><img loading=\"lazy\" decoding=\"async\" width=\"850\" height=\"1100\" src=\"https:\/\/myeloma.ca\/wp-content\/uploads\/Paper-canrevalue-patient-engagement.png\" class=\"attachment-full size-full\" alt=\"\" srcset=\"https:\/\/myeloma.ca\/wp-content\/uploads\/Paper-canrevalue-patient-engagement.png 850w, https:\/\/myeloma.ca\/wp-content\/uploads\/Paper-canrevalue-patient-engagement-232x300.png 232w, https:\/\/myeloma.ca\/wp-content\/uploads\/Paper-canrevalue-patient-engagement-791x1024.png 791w, https:\/\/myeloma.ca\/wp-content\/uploads\/Paper-canrevalue-patient-engagement-768x994.png 768w\" sizes=\"auto, (max-width: 850px) 100vw, 850px\" \/><\/div>\n                        <div class=\"content\">\n                <glwrap><\/p>\n<h3>Consultez l\u2019article intitul\u00e9 \u00ab Engaging Patients in the Canadian Real-World Evidence for Value in Cancer Drugs (CanREValue) Initiative \u00bb (en anglais)<\/h3>\n<p style=\"margin: 6px 0 2px;\">William K. Evans, Pam Takhar, Valerie McDonald, <strong>Martine Elias<\/strong>, Louise Binder, St\u00e9phanie Michaud, Mina Tadrous, Caroline Mu\u00f1oz, Kelvin K. W. Chan<\/p>\n<p style=\"font-size: 0.85em; color: #888888; margin: 0 0 10px;\">publi\u00e9 en ao\u00fbt 2022 dans la revue <em>Current Oncology<\/em><\/p>\n<hr style=\"margin: 10px 0 14px;\">\n<p>Pr\u00e9sente la fa\u00e7on dont les d\u00e9fenseurs des droits des patients, dont My\u00e9lome Canada, ont contribu\u00e9 \u00e0 l&rsquo;\u00e9laboration d&rsquo;un cadre national visant \u00e0 int\u00e9grer les donn\u00e9es probantes en contexte de vie r\u00e9elle aux d\u00e9cisions de financement des m\u00e9dicaments contre le cancer, et met en lumi\u00e8re des approches visant \u00e0 mieux int\u00e9grer la voix des patients \u00e0 ce processus.<\/p>\n<p><div class=\"lb-button-wrapper\"><a class=\"btn-with-icon \" target=\"_blank\" href=\"https:\/\/doi.org\/10.3390\/curroncol29080443\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" width=\"20\" height=\"20\" viewBox=\"0 0 20 20\"> <g transform=\"translate(-406 -2843)\"> <circle cx=\"10\" cy=\"10\" r=\"10\" transform=\"translate(406 2843)\" fill=\"#1c596c\"\/> <g transform=\"translate(412.135 2845)\"> <g transform=\"translate(10.732 7.866) rotate(135)\"> <path d=\"M0,4.968V0H4.968\" transform=\"translate(3.389 2.774)\" fill=\"none\" stroke=\"#fff\" stroke-linecap=\"round\" stroke-miterlimit=\"10\" stroke-width=\"1\"\/> <\/g> <\/g> <\/g> <\/svg><span>Lire l&rsquo;\u00e9tude<\/span><\/a><\/div><br \/>\n<\/glwrap>\n            <\/div>\n        <\/div>\n    <\/div>\n<\/div><\/div>\n\n\n\n<div id=\"lignes-directrices-consensuelles\" class=\"wp-block-group is-layout-constrained wp-block-group-is-layout-constrained\"><div class=\" content-1-block wp-elements-529000a9fda055312462ff2dba6b4131 m-pt1  block_369c5fc39e957d18a7d82b7ad4bdf9cb  \" style=\"padding-top: 3rem;padding-bottom: var(--wp--preset--spacing--60);background-color: var(--lb--light-grey);color: #3E3A3B;\">\n    <div class=\"container\">\n\t\t        <div class=\"content\">\n\t\t\t<h2 style=\"text-align: center;\">Lignes directrices consensuelles et recommandations de pratique clinique<\/h2>\n        <\/div>\n    <\/div>\n<\/div>\n\n<div class=\" horizontal-card-block wp-elements-5686ce431e1991af53086087a6385d60   block_82e54f8e82d9dfd13fb97c230ab245e7\" style=\"padding-top: var(--wp--preset--spacing--30);padding-bottom: var(--wp--preset--spacing--60);background-color: var(--lb--light-grey);color: #3E3A3B;\">\n    <div class=\"container\">\n        <div>\n                            <div class=\"horizontal-card-icon\"><img loading=\"lazy\" decoding=\"async\" width=\"850\" height=\"1100\" src=\"https:\/\/myeloma.ca\/wp-content\/uploads\/Paper-mrd-testing-infrastructure.png\" class=\"attachment-full size-full\" alt=\"\" srcset=\"https:\/\/myeloma.ca\/wp-content\/uploads\/Paper-mrd-testing-infrastructure.png 850w, https:\/\/myeloma.ca\/wp-content\/uploads\/Paper-mrd-testing-infrastructure-232x300.png 232w, https:\/\/myeloma.ca\/wp-content\/uploads\/Paper-mrd-testing-infrastructure-791x1024.png 791w, https:\/\/myeloma.ca\/wp-content\/uploads\/Paper-mrd-testing-infrastructure-768x994.png 768w\" sizes=\"auto, (max-width: 850px) 100vw, 850px\" \/><\/div>\n                        <div class=\"content\">\n                <glwrap><\/p>\n<h3>Consultez l\u2019article intitul\u00e9 \u00ab Minimal Residual Disease Testing Infrastructure in Multiple Myeloma: Guidance for Clinical Trial and Routine Practice Use in Canada \u00bb (en anglais)<\/h3>\n<p style=\"margin: 6px 0 2px;\">Hira S. Mian, Alissa Visram, Steven Chun-Min Shih, Suzanne Trudel, Annette E. Hay, Richard LeBlanc, Michael Sebag, Rayan Kaedbey, Julie Stakiw, Irwindeep Sandhu, Chai W. Phua, Philip G. Kuruvilla, Ibraheem Othman, Graeme Quest, David McMullen, <strong>Gabriele Colasurdo<\/strong>, Rami Kotb, Christopher P. Venner<\/p>\n<p style=\"font-size: 0.85em; color: #888888; margin: 0 0 10px;\">publi\u00e9 en juin 2025 dans la revue <em>Clinical Lymphoma, Myeloma &#038; Leukemia<\/em><\/p>\n<hr style=\"margin: 10px 0 14px;\">\n<p>Reviews the current state of minimal residual disease (MRD) testing across Canada and offers practical guidance for using it consistently in both clinical trials and everyday practice. <\/p>\n<p><div class=\"lb-button-wrapper\"><a class=\"btn-with-icon \" target=\"_blank\" href=\"https:\/\/www.clinical-lymphoma-myeloma-leukemia.com\/article\/S2152-2650(25)00020-5\/fulltext\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" width=\"20\" height=\"20\" viewBox=\"0 0 20 20\"> <g transform=\"translate(-406 -2843)\"> <circle cx=\"10\" cy=\"10\" r=\"10\" transform=\"translate(406 2843)\" fill=\"#1c596c\"\/> <g transform=\"translate(412.135 2845)\"> <g transform=\"translate(10.732 7.866) rotate(135)\"> <path d=\"M0,4.968V0H4.968\" transform=\"translate(3.389 2.774)\" fill=\"none\" stroke=\"#fff\" stroke-linecap=\"round\" stroke-miterlimit=\"10\" stroke-width=\"1\"\/> <\/g> <\/g> <\/g> <\/svg><span>Lire l&rsquo;\u00e9tude<\/span><\/a><\/div><br \/>\n<\/glwrap>\n            <\/div>\n        <\/div>\n    <\/div>\n<\/div>\n\n<div class=\" horizontal-card-block wp-elements-b2ab19bb35680b2c1c5eca2e57b367c1   block_b74b4779932731b663b4c6491a4b9c4f\" style=\"padding-top: var(--wp--preset--spacing--30);padding-bottom: var(--wp--preset--spacing--60);background-color: var(--lb--light-grey);color: #3E3A3B;\">\n    <div class=\"container\">\n        <div>\n                            <div class=\"horizontal-card-icon\"><img loading=\"lazy\" decoding=\"async\" width=\"850\" height=\"1100\" src=\"https:\/\/myeloma.ca\/wp-content\/uploads\/Paper-first-line-temm.png\" class=\"attachment-full size-full\" alt=\"\" srcset=\"https:\/\/myeloma.ca\/wp-content\/uploads\/Paper-first-line-temm.png 850w, https:\/\/myeloma.ca\/wp-content\/uploads\/Paper-first-line-temm-232x300.png 232w, https:\/\/myeloma.ca\/wp-content\/uploads\/Paper-first-line-temm-791x1024.png 791w, https:\/\/myeloma.ca\/wp-content\/uploads\/Paper-first-line-temm-768x994.png 768w\" sizes=\"auto, (max-width: 850px) 100vw, 850px\" \/><\/div>\n                        <div class=\"content\">\n                <glwrap><\/p>\n<h3>Consultez l\u2019article intitul\u00e9 \u00ab First Line Treatment of Newly Diagnosed Transplant Eligible Multiple Myeloma: Recommendations From a Canadian Consensus Guideline Consortium \u00bb (en anglais)<\/h3>\n<p style=\"margin: 6px 0 2px;\">Sahar Khan, Debra J. Bergstrom, Julie C\u00f4t\u00e9, Rami Kotb, Richard LeBlanc, Martha L. Louzada, Hira S. Mian, Ibraheem Othman, <strong>Gabriele Colasurdo<\/strong>, Alissa Visram<\/p>\n<p style=\"font-size: 0.85em; color: #888888; margin: 0 0 10px;\">publi\u00e9 en mars 2025 dans la revue <em>Clinical Lymphoma, Myeloma &#038; Leukemia<\/em><\/p>\n<hr style=\"margin: 10px 0 14px;\">\n<p>Recommandations consensuelles d&rsquo;experts canadiens pour le traitement des patients nouvellement diagnostiqu\u00e9s atteints d&rsquo;un my\u00e9lome et admissibles \u00e0 une greffe de cellules souches.<\/p>\n<p><div class=\"lb-button-wrapper\"><a class=\"btn-with-icon \" target=\"_blank\" href=\"https:\/\/www.clinical-lymphoma-myeloma-leukemia.com\/article\/S2152-2650(24)02385-1\/fulltext\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" width=\"20\" height=\"20\" viewBox=\"0 0 20 20\"> <g transform=\"translate(-406 -2843)\"> <circle cx=\"10\" cy=\"10\" r=\"10\" transform=\"translate(406 2843)\" fill=\"#1c596c\"\/> <g transform=\"translate(412.135 2845)\"> <g transform=\"translate(10.732 7.866) rotate(135)\"> <path d=\"M0,4.968V0H4.968\" transform=\"translate(3.389 2.774)\" fill=\"none\" stroke=\"#fff\" stroke-linecap=\"round\" stroke-miterlimit=\"10\" stroke-width=\"1\"\/> <\/g> <\/g> <\/g> <\/svg><span>Lire l&rsquo;\u00e9tude<\/span><\/a><\/div><br \/>\n<\/glwrap>\n            <\/div>\n        <\/div>\n    <\/div>\n<\/div>\n\n<div class=\" horizontal-card-block wp-elements-b8c2c12eea4337f29dea063d52f647f5   block_091f52e30e1d35d34e0d0d1d0b68652d\" style=\"padding-top: var(--wp--preset--spacing--30);padding-bottom: var(--wp--preset--spacing--60);background-color: var(--lb--light-grey);color: #3E3A3B;\">\n    <div class=\"container\">\n        <div>\n                            <div class=\"horizontal-card-icon\"><img loading=\"lazy\" decoding=\"async\" width=\"850\" height=\"1100\" src=\"https:\/\/myeloma.ca\/wp-content\/uploads\/Paper-t-cell-redirecting-therapies.png\" class=\"attachment-full size-full\" alt=\"\" srcset=\"https:\/\/myeloma.ca\/wp-content\/uploads\/Paper-t-cell-redirecting-therapies.png 850w, https:\/\/myeloma.ca\/wp-content\/uploads\/Paper-t-cell-redirecting-therapies-232x300.png 232w, https:\/\/myeloma.ca\/wp-content\/uploads\/Paper-t-cell-redirecting-therapies-791x1024.png 791w, https:\/\/myeloma.ca\/wp-content\/uploads\/Paper-t-cell-redirecting-therapies-768x994.png 768w\" sizes=\"auto, (max-width: 850px) 100vw, 850px\" \/><\/div>\n                        <div class=\"content\">\n                <glwrap><\/p>\n<h3>Consultez l\u2019article intitul\u00e9 \u00ab Recommendations for the Effective Use of T-Cell-Redirecting Therapies: A Canadian Consensus Statement \u00bb (en anglais)<\/h3>\n<p style=\"margin: 6px 0 2px;\">Guido Lancman, Kevin Song, Darrell White, Tina Crosbie, Ismail Sharif, Marianne Emond, Muhammad Saleem Raza, <strong>Martine Elias<\/strong>, Rayan Kaedbey, Michael P. Chu<\/p>\n<p style=\"font-size: 0.85em; color: #888888; margin: 0 0 10px;\">publi\u00e9 en novembre 2024 dans la revue <em>Frontiers in Oncology<\/em><\/p>\n<hr style=\"margin: 10px 0 14px;\">\n<p>Consensus d&rsquo;experts canadiens sur la s\u00e9lection des patients, le r\u00e9f\u00e9rencement et la prise en charge des effets secondaires li\u00e9s \u00e0 deux des plus r\u00e9centes cat\u00e9gories de traitements contre le my\u00e9lome : la th\u00e9rapie cellulaire de type CAR-T et les anticorps bisp\u00e9cifiques.<\/p>\n<p><div class=\"lb-button-wrapper\"><a class=\"btn-with-icon \" target=\"_blank\" href=\"https:\/\/doi.org\/10.3389\/fonc.2024.1446995\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" width=\"20\" height=\"20\" viewBox=\"0 0 20 20\"> <g transform=\"translate(-406 -2843)\"> <circle cx=\"10\" cy=\"10\" r=\"10\" transform=\"translate(406 2843)\" fill=\"#1c596c\"\/> <g transform=\"translate(412.135 2845)\"> <g transform=\"translate(10.732 7.866) rotate(135)\"> <path d=\"M0,4.968V0H4.968\" transform=\"translate(3.389 2.774)\" fill=\"none\" stroke=\"#fff\" stroke-linecap=\"round\" stroke-miterlimit=\"10\" stroke-width=\"1\"\/> <\/g> <\/g> <\/g> <\/svg><span>Lire l&rsquo;\u00e9tude<\/span><\/a><\/div><br \/>\n<\/glwrap>\n            <\/div>\n        <\/div>\n    <\/div>\n<\/div>\n\n<div class=\" horizontal-card-block wp-elements-12680abf86a0f24e54eb042b31eba717   block_604c64d0ea53e68a6384932713a71a9a\" style=\"padding-top: var(--wp--preset--spacing--30);padding-bottom: 5rem;background-color: var(--lb--light-grey);color: #3E3A3B;\">\n    <div class=\"container\">\n        <div>\n                            <div class=\"horizontal-card-icon\"><img loading=\"lazy\" decoding=\"async\" width=\"850\" height=\"1100\" src=\"https:\/\/myeloma.ca\/wp-content\/uploads\/Paper-diagnosis-consensus-guidelines-2020.png\" class=\"attachment-full size-full\" alt=\"\" srcset=\"https:\/\/myeloma.ca\/wp-content\/uploads\/Paper-diagnosis-consensus-guidelines-2020.png 850w, https:\/\/myeloma.ca\/wp-content\/uploads\/Paper-diagnosis-consensus-guidelines-2020-232x300.png 232w, https:\/\/myeloma.ca\/wp-content\/uploads\/Paper-diagnosis-consensus-guidelines-2020-791x1024.png 791w, https:\/\/myeloma.ca\/wp-content\/uploads\/Paper-diagnosis-consensus-guidelines-2020-768x994.png 768w\" sizes=\"auto, (max-width: 850px) 100vw, 850px\" \/><\/div>\n                        <div class=\"content\">\n                <glwrap><\/p>\n<h3>Consultez l\u2019article intitul\u00e9 \u00ab Consensus Guidelines on the Diagnosis of Multiple Myeloma and Related Disorders: Recommendations of the Myeloma Canada Research Network Consensus Guideline Consortium \u00bb (en anglais)<\/h3>\n<p style=\"margin: 6px 0 2px;\">Debra J. Bergstrom, Rami Kotb, Martha L. Louzada, Heather J. Sutherland, Sofia Tavoularis, Christopher P. Venner, on behalf of the Myeloma Canada Research Network Consensus Guideline Consortium<\/p>\n<p style=\"font-size: 0.85em; color: #888888; margin: 0 0 10px;\">publi\u00e9 en juillet 2020 dans la revue <em>Clinical Lymphoma, Myeloma &#038; Leukemia<\/em> \u00b7 \u00c9labor\u00e9es avec la contribution de <strong>Gabriele Colasurdo<\/strong>, de My\u00e9lome Canada.<\/p>\n<hr style=\"margin: 10px 0 14px;\">\n<p>Recommandations consensuelles nationales pour le diagnostic du my\u00e9lome multiple et des affections connexes, visant \u00e0 uniformiser les tests \u00e0 l&rsquo;\u00e9chelle du pays.<\/p>\n<p><div class=\"lb-button-wrapper\"><a class=\"btn-with-icon \" target=\"_blank\" href=\"https:\/\/www.clinical-lymphoma-myeloma-leukemia.com\/article\/S2152-2650(20)30064-1\/fulltext\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" width=\"20\" height=\"20\" viewBox=\"0 0 20 20\"> <g transform=\"translate(-406 -2843)\"> <circle cx=\"10\" cy=\"10\" r=\"10\" transform=\"translate(406 2843)\" fill=\"#1c596c\"\/> <g transform=\"translate(412.135 2845)\"> <g transform=\"translate(10.732 7.866) rotate(135)\"> <path d=\"M0,4.968V0H4.968\" transform=\"translate(3.389 2.774)\" fill=\"none\" stroke=\"#fff\" stroke-linecap=\"round\" stroke-miterlimit=\"10\" stroke-width=\"1\"\/> <\/g> <\/g> <\/g> <\/svg><span>Lire l&rsquo;\u00e9tude<\/span><\/a><\/div><br \/>\n<\/glwrap>\n            <\/div>\n        <\/div>\n    <\/div>\n<\/div><\/div>\n","protected":false},"excerpt":{"rendered":"<p>On this page Les contributions de notre \u00e9quipe \u00e0 la recherche sur le my\u00e9lome<\/p>\n","protected":false},"author":18,"featured_media":0,"parent":6268,"menu_order":2,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"tags":[],"class_list":["post-36113","page","type-page","status-publish","hentry"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/pages\/36113","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/users\/18"}],"replies":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/comments?post=36113"}],"version-history":[{"count":8,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/pages\/36113\/revisions"}],"predecessor-version":[{"id":36258,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/pages\/36113\/revisions\/36258"}],"up":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/pages\/6268"}],"wp:attachment":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/media?parent=36113"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/tags?post=36113"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}